by Coopersmith,
Craig M.; De Backer, Daniel; Deutschman, Clifford S.; Ferrer, Ricard; Lat,
Ishaq; Machado, Flavia R.; Martin, Greg S.; Martin-Loeches, Ignacio; Nunnally,
Mark E.; Antonelli, Massimo; Evans, Laura E.; Hellman, Judith; Jog, Sameer;
Kesecioglu, Jozef; Levy, Mitchell M.; Rhodes, Andrew
Objective: To identify
research priorities in the management, epidemiology, outcome and underlying
causes of sepsis and septic shock. Design: A consensus committee of 16
international experts representing the European Society of Intensive Care
Medicine and Society of Critical Care Medicine was convened at the annual
meetings of both societies. Subgroups had teleconference and electronic-based
discussion. The entire committee iteratively developed the entire document and recommendations.
Methods: Each committee member independently gave their top five priorities for
sepsis research. A total of 88 suggestions (Supplemental Table 1, Supplemental
Digital Content 2, http://links.lww.com/CCM/D636) were grouped into categories
by the committee co-chairs, leading to the formation of seven subgroups:
infection, fluids and vasoactive agents, adjunctive therapy,
administration/epidemiology, scoring/identification, post-intensive care unit,
and basic/translational science. Each subgroup had teleconferences to go over
each priority followed by formal voting within each subgroup. The entire
committee also voted on top priorities across all subgroups except for
basic/translational science. Results: The Surviving Sepsis Research Committee provides
26 priorities for sepsis and septic shock. Of these, the top six clinical
priorities were identified and include the following questions: 1) can
targeted/personalized/precision medicine approaches determine which therapies
will work for which patients at which times?; 2) what are ideal endpoints for
volume resuscitation and how should volume resuscitation be titrated?; 3)
should rapid diagnostic tests be implemented in clinical practice?; 4) should
empiric antibiotic combination therapy be used in sepsis or septic shock?; 5)
what are the predictors of sepsis long-term morbidity and mortality?; and 6)
what information identifies organ dysfunction? Conclusions: While the Surviving
Sepsis Campaign guidelines give multiple recommendations on the treatment of
sepsis, significant knowledge gaps remain, both in bedside issues directly
applicable to clinicians, as well as understanding the fundamental mechanisms
underlying the development and progression of sepsis. The priorities identified
represent a roadmap for research in sepsis and septic shock.
No comments:
Post a Comment